|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Subscription | |||||
| Professional services and other | |||||
| Total revenue | |||||
| Cost of revenue | |||||
| Subscription | |||||
| Professional services and other | |||||
| Total cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Sales and marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Restructuring and other related charges | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Interest expense | |||||
| Interest income and other income, net | |||||
| Income before provision for (benefit from) income taxes | |||||
| Provision for (benefit from) income taxes | |||||
| Net income | |||||
| Net income per share attributable to common stockholders: | |||||
| Basic (in usd per share) | |||||
| Diluted (in usd per share) | |||||
| Weighted-average shares used in computing net income per share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Other comprehensive income (loss): | |||||
| Foreign currency translation gains (losses), net of tax | |||||
| Unrealized gains on investments, net of tax | |||||
| Other comprehensive income (loss) | |||||
| Comprehensive income | |||||
| Stock-based compensation expense | |||||
| Sales and marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Restructuring and other related charges | |||||
| Total stock-based compensation expense | |||||
Loading...